Cipher PharmaceuticalsCipher is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products ProductsPipeline NewsCipher Pharmaceuticals Appoints Mr. Craig Mull to the Board of Directors March 26, 2019Cipher Pharmaceuticals Announces Change to Management Team March 20, 2019Events Tuesday, March 19, 2019 8:30 am ET Q4 2018 Results Conference Call/Webcast Call in Numbers (416) 764-8609 or (888) 390-0605 Webcast Replay Call in Number (888) 390-0541 (playback code 671895) Available until March 26 midnight Investors Financial Reports Investor Presentation Corporate Governance Documents Webcasts
